We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma Companies Defend Themselves After HIV Drug Pricing Criticism
Pharma Companies Defend Themselves After HIV Drug Pricing Criticism
August 11, 2011
Several pharma companies are defending their decisions to end discount prices for HIV drugs in middle-income countries following criticism from Doctors Without Borders (DWB).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor